A randomized trial to investigate the efficacy and safety of once‐daily liraglutide 1.8 mg in Japanese adults with type 2 diabetes exhibiting an inadequate response to liraglutide 0.9 mg

A randomized trial to investigate the efficacy and safety of once‐daily liraglutide 1.8 mg in Japanese adults with type 2 diabetes exhibiting an inadequate response to liraglutide 0.9 mg

ABSTRACT Aims/Introduction The present trial compared the efficacy and safety of once‐daily liraglutide 1.8 mg with liraglutide 0.9 mg in Japanese patients with type 2 diabetes to assess the incremental effects of liraglutide 1.8 mg in those who exhibited an inadequate response to 0.9 mg. Materials...

Full description

Bibliographic Details
Main Authors: Yutaka Seino, Hideaki Miyoshi, Heidrun Bosch Traberg, T V S Divyalasya, Keiji Nishijima, Yasuo Terauchi
Format: Article
Language:English
Published: Wiley 2022-08-01
Series:Journal of Diabetes Investigation
Subjects:
Glucagon‐like peptide‐1
Liraglutide
Type 2 diabetes mellitus
Online Access:https://doi.org/10.1111/jdi.13789

Internet

https://doi.org/10.1111/jdi.13789

Similar Items